Clinical Trial Update: TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating TETRAVI Multivirus CTLs to treat EBV, CMV, adenovirus, and BK virus infections in patients after allogeneic stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• TETRAVI Multivirus CTL

Snippet

Sponsor: Baylor College of Medicine | Conditions: Viral Infection | Phase 1 | Status: RECRUITING